|
1
|
Gurtan AM and Sharp PA: The role of miRNAs
in regulating gene expression networks. J Mol Biol. 425:3582–3600.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baek D, Villén J, Shin C, Camargo FD, Gygi
SP and Bartel DP: The impact of microRNAs on protein output.
Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu D, Li M, Wang L, Zhou Y, Zhou J, Pan H
and Qu P: microRNA145 inhibits cell proliferation, migration and
invasion by targeting matrix metallopeptidase-11 in renal cell
carcinoma. Mol Med Rep. 10:393–398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu D, Pan H, Zhou Y, Zhang Z, Qu P, Zhou J
and Wang W: Upregulation of microRNA-204 inhibits cell
proliferation, migration and invasion in human renal cell carcinoma
cells by downregulating SOX4. Mol Med Rep. 12:7059–7064. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: Key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ljungberg B, Campbell SC, Choi HY, Jacqmin
D, Lee JE, Weikert S and Kiemeney LA: The epidemiology of renal
cell carcinoma. Eur Urol. 60:615–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Capitanio U and Montorsi F: Renal cancer.
Lancet. 387:894–906. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
De Meerleer G, Khoo V, Escudier B, Joniau
S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N,
et al: Radiotherapy for renal-cell carcinoma. Lancet Oncol.
15:e170–e177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song C, Xu Z, Jin Y, Zhu M, Wang K and
Wang N: The network of microRNAs, transcription factors, target
genes and host genes in human renal cell carcinoma. Oncol Lett.
9:498–506. 2015.PubMed/NCBI
|
|
18
|
Gao Y, Ma X, Yao Y, Li H, Fan Y, Zhang Y,
Zhao C, Wang L, Ma M, Lei Z and Zhang X: miR-155 regulates the
proliferation and invasion of clear cell renal cell carcinoma cells
by targeting E2F2. Oncotarget. 7:20324–20337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang
Z, Wang X, Lin Y, Mao Y, et al: Downregulation of microRNA-182-5p
contributes to renal cell carcinoma proliferation via activating
the AKT/FOXO3a signaling pathway. Mol Cancer. 13:1092014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X,
Zheng L, Xue Z, Xia W, Zhang B, et al: MicroRNA-99a induces
G1-phase cell cycle arrest and suppresses tumorigenicity in renal
cell carcinoma. BMC Cancer. 12:5462012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tu HF, Chang KW, Cheng HW and Liu CJ:
Upregulation of miR-372 and −373 associates with lymph node
metastasis and poor prognosis of oral carcinomas. Laryngoscope.
125:E365–E370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu A, Li J, Wu K, Mo Y, Luo Y, Ye H, Shen
X, Li S, Liang Y, Liu M and Yang Z: MiR-373-3p Promotes invasion
and metastasis of lung adenocarcinoma cells. Zhongguo Fei Ai Za
Zhi. 18:427–435. 2015.(In Chinese). PubMed/NCBI
|
|
23
|
Chen D, Dang BL, Huang JZ, Chen M, Wu D,
Xu ML, Li R and Yan GR: MiR-373 drives the
epithelial-to-mesenchymal transition and metastasis via the
miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
Oncotarget. 6:32701–32712. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou C, Shen L, Mao L, Wang B, Li Y and Yu
H: miR-92a is upregulated in cervical cancer and promotes cell
proliferation and invasion by targeting FBXW7. Biochem Biophys Res
Commun. 458:63–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu J, Lv G, Zhou S, Zhou Y, Nie B, Duan H,
Zhang Y and Yuan X: The downregulation of MiR-182 is associated
with the growth and invasion of osteosarcoma cells through the
regulation of TIAM1 expression. PLoS One. 10:e01211752015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang DQ, Zhou CK, Jiang XW, Chen J and
Shi BK: Increased expression of miR-222 is associated with poor
prognosis in bladder cancer. World J Surg Oncol. 12:2412014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu W, Li M, Chen X, Zhang D, Wei L, Zhang
Z, Wang S, Meng L, Zhu S and Li B: Erratum: MicroRNA-373 promotes
migration and invasion in human esophageal squamous cell carcinoma
by inhibiting TIMP3 expression. Am J Cancer Res. 6:1–14. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang LQ, Zhang Y, Yan H, Liu KJ and Zhang
S: MicroRNA-373 functions as an oncogene and targets YOD1 gene in
cervical cancer. Biochem Biophys Res Commun. 459:515–520. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Li X, Tan Z, Liu X, Yang C, Ding
X, Hu X, Zhou J, Xiang S, Zhou C and Zhang J: MicroRNA-373 is
upregulated and targets TNFAIP1 in human gastric cancer,
contributing to tumorigenesis. Oncol Lett. 6:1427–1434.
2013.PubMed/NCBI
|
